Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.9.4815

(-)-Epigallocatechin-3-Gallate Induces Apoptosis and Inhibits Invasion and Migration of Human Cervical Cancer Cells  

Sharma, Chhavi (Department of Biotechnology, Manipal University)
Nusri, Qurrat El-Ain (Department of Biotechnology, Manipal University)
Begum, Salema (Department of Biotechnology, Manipal University)
Javed, Elham (Department of Biotechnology, Manipal University)
Rizvi, Tahir A. (Department of Microbiology and Immunology, Faculty of Medicine and Health Science, UAE University)
Hussain, Arif (Department of Biotechnology, Manipal University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.9, 2012 , pp. 4815-4822 More about this Journal
Abstract
Invasion and metastasis are the major causes of cancer-related death. Pharmacological or therapeutic interventions such as chemoprevention of the progression stages of neoplastic development could result in substantial reduction in the incidence of cancer mortality. (-)-Epigallocatechin-3-gallate (EGCG), a promising chemopreventive agent, has attracted extensive interest for cancer therapy utilizing its antioxidant, anti-proliferative and inhibitory effects on angiogenesis and tumor cell invasion. In this study, we assessed the influence of EGCG on the proliferative potential of HeLa cells by cell viability assay and authenticated the results by nuclear morphological examination, DNA laddering assay and cell cycle analysis. Further we analyzed the anti-invasive properties of EGCG by wound migration assay and gene expression of MMP-9 and TIMP-1 in HeLa cells. Our results indicated that EGCG induced growth inhibition of HeLa cells in a dose- and time-dependent manner. It was observed that cell death mediated by EGCG was through apoptosis. Interestingly, EGCG effectively inhibited invasion and migration of HeLa cells and modulated the expression of related genes (MMP-9 and TIMP-1). These results indicate that EGCG may effectively suppress promotion and progression stages of cervical cancer development.
Keywords
Epigallocatechin-3-gallate; invasion; matrix metalloproteinases-9; cervical cancer;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Agarwal C, Sharma Y, Agarwal R (2000). Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells. modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis. Mol Carcinog, 28, 129-38.   DOI
2 Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997). Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst, 89, 1881-6.   DOI   ScienceOn
3 Artali R, Beretta G, Morazzoni P, Bombardelli E, Meneghetti F (2009). Green tea catechins in chemoprevention of cancer. a molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1). J Enzyme Inhib Med Chem, 24, 287-95.   DOI
4 Aziz MH, Kumar R, Ahmad N (2003). Cancer chemoprevention by resveratrol. In vitro and in vivo studies and the underlying mechanisms. Int J Oncol, 23,17-28.
5 Baek SM, Kwon CH, Kim JH, et al (2003). Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med, 142, 178-86.   DOI
6 Bal DG, Foerster SB, Backman DR, Lyman DO (2001). Dietary change and cancer. challenges and future direction. J Nutr, 131,181-5.
7 Chan CM, Huang JH, Chiang HS, et al (2010). Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion. Molecular Vision, 16, 586-95.
8 Chen JJ, YE Z, Koo MWL (2004). Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBTII bladder tumor cell line. BJU International, 93,1082-6.   DOI
9 Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998). Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 92, 996-1002.
10 D'Agostini F, Izzotti A, Balansky RM, Bennicelli C, De Flora S (2005). Modulation of apoptosis by cancer chemopreventive agents. Mutat Res, 591,173-86.   DOI
11 Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N (2000). Metalloproteinases. role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res, 2, 252-7.   DOI   ScienceOn
12 Farabegoli F, Papi A, Orlandi M (2011). (-)-Epigallocatechin- 3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifenresistant cells. Biosci Rep, 31, 99-108.   DOI
13 Giannelli G, Antonaci S (2005). MMP and TIMP assay in cancer. Biological and clinical significance. Int J Cancer, 116, 1002-3.   DOI
14 Gomis-Ruth FX, Maskos K, Betz M, et al (1997). Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature, 389, 77-81.   DOI
15 Gu B, Ding Q, Xia G, Fang Z (2009). EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression. Oncol Rep, 21, 635-40.
16 Gupta S, Hussain T, Mukhtar H (2003). Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys, 410, 177-85.   DOI   ScienceOn
17 Gupta S, Pramanik D, Mukherjee R, et al (2011). Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer. Clin Cancer Res, 11, 2165.
18 Holten-Andersen MN, Murphy G, Nielsen HJ, et al (1999). Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer, 80, 495-503.   DOI
19 Harakeh S, Abu-El-Ardat K, Diab-Assaf M, et al (2008). Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells. Med Oncol, 25,30-9.   DOI
20 Hibasami H, Achiwa Y, Fujikawa T, Komiya T (1996). Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res, 16, 1943-6.
21 Hsu YC, Liou YM (2011). The anti-cancer effects of (-)-epigallocatechin-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J Cell Physiol, 226, 2721-30.   DOI
22 Huh SW, Bae SM, Kim YW, et al (2004). Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol, 94, 760-8.   DOI   ScienceOn
23 Jones JL, Glynn P, Walker RA (1999). Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol, 189, 161-8.   DOI
24 Jung YD, Kim MS, Shin BA, et al (2001). EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer, 84, 844-50.   DOI   ScienceOn
25 Kazi A, Smith DM, Zhong Q, Dou QP (2002). Inhibition of Bcl- XL Phosphorylation by Tea Polyphenols or Epigallocatechin- 3-Gallate Is Associated with Prostate Cancer Cell Apoptosis. Mol Pharmacol, 62, 765-71.   DOI
26 Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006). Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res, 66, 2500-5.   DOI
27 Lambert E, Dasse E, Haye B, Petitfrere E (2004). TIMPs as multifacial proteins. Crit Rev Oncol Hematol, 49, 187-98.   DOI
28 Khuri FR, Kim ES, Lee JJ, et al (2001). The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev, 10, 823-9.
29 Kim C, Moon S (2005). Epigallocatechin-3-gallate causes the p21/WAF1-mediated G1-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF- ${\alpha}$-induced vascular smooth muscle cells. Arch Biochem Biophy, 435, 264-72.   DOI
30 Kim HS, Kim MH, Jeong M, et al (2004). EGCG Blocks Tumor Promoter-induced MMP-9 Expression Via Suppression of MAPK and AP-1 Activation in Human Gastric AGS Cells. Anticancer Res, 24, 747-54.
31 Lambert JD, Yang CS (2003). Mechanisms of cancer prevention by tea constituents. J Nutr, 133, 3262-7.
32 Lee HS, Seo EY, Kang NE, Kim WK (2008). (6)-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem, 19, 313-9.   DOI
33 Li HC, Yashiki S, Sonoda J, et al (2000). Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients. Jpn J Cancer Res, 91, 34-40.   DOI
34 Li Y, Che M, Bhagat S, et al (2004). Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia, 6, 354-63.   DOI
35 Liang YC, Lin-Shiau SY, Chen CF, Lin JK (1999). Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3- gallate. J Cell Biochem, 75, 1-12.
36 Park JH, Yoon JH, Kim SA, Ahn SG, Yoon JH (2010). (-)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells. Oncol Rep, 23, 585-90.
37 Maeda-Yamamoto M, Suzuki N, Sawai Y, et al (2003). Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT 1080 cells. J Agric Food Chem, 51, 1858-63.   DOI
38 Matsuura N, Miyamae Y, Yamane K, et al (2006). Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr, 136, 842-6.
39 Moongkarndi P, Kosem N, Kaslungka S, et al (2004). Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol, 90, 161-6.   DOI
40 Punathil T, Tollefsbol TO, Katiyar SK (2008). EGCG inhibits cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclise. Biochem Biophys Res Commun, 375, 162-7.   DOI
41 Qanungo S, Das M, Haldar S, Basu A (2005). Epigallocatechin- 3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis, 26, 958-67.
42 Qi W, Weber CR, Wasland K, Savkovic SD (2011). Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer, 11, 219.   DOI
43 Qiao Y, Cao J, Xie L, Shi X (2009). Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells. Arch Pharm Res, 32, 1309-15.   과학기술학회마을   DOI
44 Seeram NP, Henning SM, Niu Y, et al (2006). Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agric Food Chem, 54, 1599-603.   DOI
45 Rao SD, Pagidas K (2010). Epigallocatechin-3-gallate, a Natural Polyphenol, Inhibits Cell Proliferation and Induces Apoptosis in Human Ovarian Cancer Cells. Anticancer Res, 30, 2519-24.
46 Roomi MW, Monterrey JC, Kalinovsky T, Rath M, Niedzwiecki A (2010). Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. Oncol Rep, 24, 747-57.
47 Roy M, Siddiqi M, Bhattacharya RK (2001). Cancer Chemoprevention. Tea Polyphenol Induced Cellular and Molecular Responses. Asian Pac J Cancer Prev, 2, 109-16.
48 Sen T, Chatterjee A (2011). Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells. involvement of integrin receptor ${\alpha}5{\beta}1$ in the process. Eur J Nutr, 50, 465-78.   DOI
49 Sen T, Dutta A, Chatterjee A (2010). Epigallocatechin-3- gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs, 21, 632-44.   DOI
50 Shankar S, Ganapathy S, Hingorani SR, Srivastava RK (2008). EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci, 13, 440-52.   DOI
51 Sharma C, Kaur J, Shishodia S, Aggarwal BB, Ralhan R (2006). Curcumin down regulates smokeless tobacco-induced NFkappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology, 228, 1-15.   DOI
52 Sporn MB (1996). The war on cancer. Lancet, 347, 1377-81.   DOI   ScienceOn
53 Sharma C, Sadrieh L, Priyani A, et al (2011). Anti-carcinogenic effects of sulforaphane in association with its apoptosisinducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol, 35, 272-8.   DOI   ScienceOn
54 Shirakami Y, Shimizu M, Adachi S, et al (2009). (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis. Cancer Sci, 100, 1957-62.   DOI
55 Siddiqui IA, Malik A, Adhami VM, et al (2008). Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene, 27, 2055-63.   DOI
56 Sporn MB, Suh N(2000). Chemoprevention of cancer. Carcinogenesis, 21, 525-30.   DOI
57 Stingl JC, Ettrich T, Muche R, et al (2011). Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE). a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population. BMC Cancer, 11, 360.   DOI
58 Takada M, Nakamura Y, Koizumi T, et al (2002). Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas, 25, 45-8.   DOI   ScienceOn
59 Takahashi H, Nomata K, Mori K, et al (2004). The preventive effect of green tea on the gap junction intercellular communication in renal epithelial cells treated with a renal carcinogen. Anticancer Res, 24, 3757-62.
60 Tang GQ, Yan TQ, Guo W, et al (2010). (-)-Epigallocatechin- 3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells. J Cancer Res Clin Oncol, 136, 1179-85.   DOI
61 Visse R, Nagase H (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases. structure, function, and biochemistry. Circ Res, 92, 827-39.   DOI   ScienceOn
62 Wels J, Kaplan RN, Rafii S, Lyden D (2008). Migratory neighbors and distant invaders. tumor-associated niche cells. Genes Dev, 22, 559-74.   DOI
63 Yang CS, Maliakal P, Meng X (2002). Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol, 42, 25-54.   DOI   ScienceOn
64 Yang G, Liao J, Kim K, Yurkow EJ, Yang CS (1998). Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis, 19, 611-6.   DOI   ScienceOn
65 Zaveri NT (2006). Green tea and its polyphenolic catechins. Medicinal uses in cancer and noncancer applications. Life Sciences, 78, 2073-80.   DOI   ScienceOn
66 Zhang W, Hashimoto K, Yu GY, Sakagami H (2002). Decline of superoxide dismutase activity during antioxidant-induced apoptosis in HL-60 cells. Anticancer Res, 22, 219-24.
67 Zhou F, Zhou H, Wang T, et al (2011). Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. Acta Pharmacol Sin, 10, 139.
68 Zhu BH, Chen HY, Zhan WH, et al (2011). (-)-Epigallocatechin- 3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World J Gastroenterol, 17, 2315-25.   DOI   ScienceOn